Legal Representation
Attorney
Omar M. Wadhwa
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Nov 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 30, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 30, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 27, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 27, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 27, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 31, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 30, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 30, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 30, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 29, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 29, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 29, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 30, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 16, 2023 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Jan 5, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Dec 6, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 6, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 31, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 31, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 31, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 31, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 31, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 8, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 21, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable software for operating and managing clinical trials by third parties; downloadable software for providing telemedicine services; downloadable software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Downloadable software for allowing clinical trial participants to provide electronic consent and withdrawn electronic consent
Class 042
Software as a service (SaaS) services featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing telemedicine services; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SaaS) services featuring software for allowing clinical trial participants to provide electronic consent and withdraw electronic consent; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing telemedicine services; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for allowing clinical trial participants to provide electronic consent and withdraw electronic consent
Classification
International Classes
009
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CONSENT"